Familial hematological malignancies: ASXL1 gene investigation
- 19 August 2015
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 18 (4) , 385-390
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Functional and cancer genomics of ASXL family membersBritish Journal of Cancer, 2013
- Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseasesJournal of Hematology & Oncology, 2012
- Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic valueHaematologica, 2011
- De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndromeNature Genetics, 2011
- Molecular study of CEPBA in familial hematological malignanciesFamilial Cancer, 2009
- Mutations of ASXL1 gene in myeloproliferative neoplasmsLeukemia, 2009
- Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemiaBritish Journal of Haematology, 2009
- Polycomb silencing mechanisms and the management of genomic programmesNature Reviews Genetics, 2007
- Additional Sex Comb-like 1 (ASXL1), in Cooperation with SRC-1, Acts as a Ligand-dependent Coactivator for Retinoic Acid ReceptorJournal of Biological Chemistry, 2006
- Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutralJournal of Medical Genetics, 2005